Alanine aminotransferase levels as therapeutic targets after nucleotide/nucleoside analog therapy in patient with chronic hepatitis B
Author:
Affiliation:
1. Department of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan
2. Department of Gastroenterology and Hepatology Tokyo Medical and Dental University Tokyo Japan
Funder
Japan Agency for Medical Research and Development
Japan Science and Technology Agency
Publisher
Wiley
Subject
Infectious Diseases,Hepatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13839
Reference45 articles.
1. Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors
2. Natural History and Hepatocellular Carcinoma Risk in Untreated Chronic Hepatitis B Patients With Indeterminate Phase
3. The natural history of chronic hepatitis B virus infection
4. Hepatitis B Virus Infection — Natural History and Clinical Consequences
5. Comparison of medication adherence and satisfaction between entecavir and tenofovir alafenamide therapy in chronic hepatitis B
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Treatment response to durvalumab plus tremelimumab after progression with previous immune checkpoint inhibitor in unresectable hepatocellular carcinoma;Investigational New Drugs;2024-08-30
2. Diagnostic significance of alanine aminotransferase isoenzymes in alcoholic and non-alcoholic fatty liver cancers;Bioscience Reports;2023-11
3. Usefulness of the Fibrosis‐4 index and alanine aminotransferase at 1 year of nucleos(t)ide analog treatment for prediction of hepatocellular carcinoma in chronic hepatitis B patients;Hepatology Research;2023-09-06
4. Switching from entecavir to tenofovir alafenamide for maintaining complete virological response in chronic hepatitis B;JGH Open;2023-07-21
5. Effect of fatty liver and fibrosis on hepatocellular carcinoma development in patients with chronic hepatitis B who received nucleic acid analog therapy;Journal of Viral Hepatitis;2023-01-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3